approval
saveCOSENTYX (SECUKINUMAB) — FDA approval
community read0 votes
Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
same company · ±60 days · 6
- approvalinclisiran: LEQVIO (INCLISIRAN SODIUM) — FDA approvalDec 22, 2021
- approvalCOSENTYX (SECUKINUMAB) — FDA approvalDec 22, 2021
- approvaldabrafenib mesylate ODT: TAFINLAR (DABRAFENIB MESYLATE) — FDA approvalDec 3, 2021
- approvalSpexotras: MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalDec 3, 2021
- approvaldabrafenib mesylate ODT: TAFINLAR (DABRAFENIB MESYLATE) — FDA approvalJan 28, 2022
- approvalSpexotras: MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalJan 28, 2022
comments(0)
5-min edit window · permanent after that